ad

Nifty Pharma Prediction for Tomorrow, 22 July 2026: Index Adds 0.34 Percent to 26,092.85, a Second Straight Gain

Nifty Pharma prediction for tomorrow 22 July 2026: index at 26,092.85, up 0.34 percent on Tuesday, a second straight gain. Support 25,880. Resistance 26,110.


21 Jul 20264:11 pm

Nifty Pharma Prediction for Tomorrow, 22 July 2026: Index Adds 0.34 Percent to 26,092.85, a Second Straight Gain

Nifty pharma prediction for tomorrow: Nifty Pharma closed at 26,092.85 on Tuesday, up 89.70 points or 0.34 percent, a second consecutive positive session that consolidates Monday’s sharp 1.40 percent rebound even as the sector’s pace of gains moderated from the prior day’s standout performance. This nifty pharma prediction for tomorrow is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.

Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Nifty Pharma prediction for tomorrow reflects a sector holding onto its recent gains rather than reversing them, a healthier pattern than a single-day spike followed by giveback, even as investor attention shifted toward the sharp commodity market moves on Tuesday.

Click Here – Get Free Investment Predictions

Market Recap Behind the Nifty pharma prediction for tomorrow

The index opened at 26,007.20, touched a high of 26,108.70 and a low of 25,878.20 before closing at 26,092.85. Ankit Jaiswal notes that while the broader pharma index posted a second straight gain, the calmer pace after Monday’s sharp move suggests the sector is consolidating its recent defensive-rotation-driven strength.

Nifty pharma prediction for tomorrow: Trend and Key Levels

Trend: Bullish Above 25,880

Level Type Value
Support 1 25,880
Support 2 25,720
Resistance 1 26,110
Resistance 2 26,250

Ankit Jaiswal flags 25,880 as the key support, with 26,110 as the near-term resistance, matching Tuesday’s high. A close above 26,250 would confirm the sector’s rally has further room, while a break under 25,720 would suggest the two-session gains are beginning to fade.

Global Cues for Nifty Pharma Tomorrow

Yemen’s Iran-aligned Houthis announced a naval blockade on Saudi Arabia on Monday, opening a fresh front in the regional conflict and pushing Brent crude back toward 90 dollars a barrel. Indian equities traded cautiously lower through Tuesday’s session, with the Nifty MidCap and SmallCap indices outperforming the headline benchmarks. HDFC Bank extended its Monday crash into a second straight session, while Nifty Cement led sectoral gains. Pharma remains largely insulated from these geopolitical and earnings-driven cues, since the sector’s fortunes depend more on US generic pricing trends and domestic demand, which continues to support its relative stability.

Key Triggers in the Nifty pharma prediction for tomorrow

These triggers dominate the outlook heading into Monday, 13 July 2026:

  • Continued sector consolidation: A third straight positive session would further confirm the defensive rotation has staying power.
  • US generic pricing developments: Any regulatory or pricing news from the US market remains an added sector-specific catalyst.
  • HDFC Bank extended its post-results crash into a second straight session on Tuesday, falling a further 2.08 percent to Rs 761.45, among Nifty 50’s biggest losers again.

Talk to a SEBI Registered Investment Advisor Before Your Next Trade

Stocks to Watch in the Pharma Sector

Key pharma constituents worth tracking alongside the broader sector outlook.

Sun Pharma: Sun Pharma is a sector bellwether worth tracking for stock-level signals within the pharma space.

Nifty Healthcare: The closely related healthcare index moved in a similarly steady fashion on Tuesday.

Risks to the Nifty pharma prediction for tomorrow

These factors can invalidate this outlook:

  • Rotation reversal: If broader market sentiment strengthens further, defensive sectors like pharma could see some profit booking.
  • US regulatory setback: Any adverse FDA decision would be a clear sector-specific negative.
  • Extended consolidation weakening: If Wednesday sees a decline, it could suggest the recent rally is genuinely fading.

Download the Univest iOS App or Univest Android App to track live Nifty Pharma levels and get daily research from SEBI registered analysts.

Conclusion

The Nifty Pharma prediction for tomorrow, 22 July 2026, is bullish above 25,880, after the sector posted a second straight gain, consolidating Monday’s sharp defensive-rotation rebound. Ankit Jaiswal flags 25,880 as the key support in the Nifty Pharma prediction for tomorrow, with continued sector consolidation the key theme heading into Wednesday.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty pharma prediction for tomorrow

What is the Nifty Pharma prediction for tomorrow, 22 July 2026?

Ans. The Nifty Pharma prediction for tomorrow, 22 July 2026, is bullish above 25,880. The index closed at 26,092.85 on Tuesday, up 0.34 percent, a second straight positive session.

Which analyst gave the Nifty Pharma prediction for tomorrow?

Ans. Ankit Jaiswal, Senior Research Analyst at Univest, has shared the Nifty Pharma prediction for tomorrow, flagging 25,880 as the key support level.

Is Nifty Pharma’s rally sustainable heading into this prediction for tomorrow?

Ans. The Nifty Pharma prediction for tomorrow notes that a second straight positive session, even at a calmer pace than Monday’s sharp rebound, is a healthier pattern than a single-day spike, suggesting the defensive rotation into pharma has some genuine staying power.

Why did Nifty Pharma’s pace of gains slow on Tuesday?

Ans. Nifty Pharma’s more modest Tuesday gain, after Monday’s sharp 1.40 percent rebound, reflects investor attention shifting toward the sharp commodity market moves following the fresh Houthi escalation, which the Nifty Pharma prediction for tomorrow reads as consolidation rather than a reversal.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down